Cost-effectiveness considerations of cardiovascular therapeutics
Related Experiment Video
Updated: Jun 24, 2026
Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
Anthony Keech1, John D Horowitz
1NHMRC Clinical Trials Centre and Department of Cardiology, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia. tony@ctc.usyd.edu.au
Abstract:
As medical knowledge advances, potential new tests and treatments are usually evaluated in randomised clinical trials and may then be adopted into clinical practice. Some are adopted because they are more effective than what went before, improving quality and/or quantity of life, others because they can achieve a similar clinical outcome at a lower cost. Comparing the costs and effects of various treatment options in the management of cardiac conditions is a fundamental process towards achieving the best outcomes for our own patients and our whole population with available resources. We all make daily decisions about treatment choices for our patients that no doubt take these issues into account, at least in a qualitative way, but formal quantitative methods are now well developed and will become increasingly important as we try to do the most good for the most people using our departmental, state and national health budgets.
Insights
Evaluating new medical treatments requires comparing costs and benefits to improve patient outcomes. Quantitative methods are essential for making informed decisions within healthcare budgets.
Area of Science:
- Health economics
- Clinical research methodology
- Cardiology
Background:
- Medical advancements necessitate rigorous evaluation of new tests and treatments.
- Adoption of new interventions is driven by improved efficacy or cost-effectiveness.
- Cardiac condition management requires careful consideration of costs and effects.
Purpose of the Study:
- To highlight the importance of comparing costs and effects for cardiac treatments.
- To emphasize the growing need for formal quantitative methods in healthcare decision-making.
- To guide resource allocation for maximizing patient benefit within budget constraints.
Main Methods:
- The abstract discusses the general principles of evaluating medical interventions.
- It emphasizes the role of randomized clinical trials in assessing new treatments.
- It advocates for the use of formal quantitative methods for cost-effectiveness analysis.
Main Results:
- New treatments are adopted if they offer superior effectiveness or better value for money.
- Qualitative considerations of cost and effect are common in daily practice.
- Formal quantitative methods provide a robust framework for these comparisons.
Conclusions:
- Comparing costs and effects is fundamental for optimal patient and population outcomes.
- Quantitative methods are increasingly crucial for efficient healthcare resource allocation.
- Informed treatment choices maximize the good achieved within available health budgets.
Related Concept Videos
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
01:30Heart Failure V: Medical Management
01:29Pathophysiology of Cardiac Performance
01:26Atherosclerosis III: Management
01:20Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...